Tag: antisense oligonucleotides (ASO) July 8, 2020 Experimental drug shows early promise against inherited form of ALS, trial indicatesPhase 1/phase 2 trial shows evidence for safety, biological activity of tofersen; phase 3 trial underway.News Release August 15, 2019 Antisense drugs for Huntington’s, ALS and prion diseases could meet the dire need for brain treatmentsSource: Scientific American July 16, 2018 New ALS therapy in clinical trialsDrug extends survival, reverses some neuromuscular damage in animals.News Release Posts navigation
